Quick Answer
Stemtech Corp reported Gross Profit of $3.73 million for the year ending 2024.
- Stemtech Corp showed a decrease of -4.9% in Gross Profit from 2023 to 2024.
- This data is from Stemtech Corp's annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $875.9 thousand | Q1 2021: $895.6 thousand | Q2 2021: $755.9 thousand | Q3 2021: $781.4 thousand | Q1 2022: $893.7 thousand | Q2 2022: $883.2 thousand | Q3 2022: $866.4 thousand | Q1 2023: $888.5 thousand | Q2 2023: $881.9 thousand | Q3 2023: $1.01 million | Q1 2024: $1.04 million | Q2 2024: $993.6 thousand | Q3 2024: $651.4 thousand | Q1 2025: $720.3 thousand | Q2 2025: $552.0 thousand | Q3 2025: $682.5 thousand.
- Over the full 5 years of available data (2020 to 2024), Stemtech Corp's Gross Profit has grown by 1.6%.
- Historical annual values: Fiscal year 2024: $3.73 million | Fiscal year 2023: $3.92 million | Fiscal year 2022: $3.40 million | Fiscal year 2021: $3.30 million | Fiscal year 2020: $3.67 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: